← Leaderboards
R Scott Lokey
University Of California Santa Cruz
$7,777,813
Attributed
$7,777,813
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,777,813 · 7
By mechanism
R01$3,949,021 · 3
S10$2,431,837 · 2
R35$1,353,856 · 1
F32$43,099 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Santa Cruz
Same institution · by research overlap
- William T. Sullivan$11,865,087
- Susan Carpenter$5,979,455
Others in their field
Top investigators on “Libraries”
- David Heimbrook · Leidos Biomedical Research, Inc.$860,725,506
- Leonard Freedman · Leidos Biomedical Research, Inc.$792,858,643
- Richard A Gibbs · Baylor College Of Medicine$428,954,539
- Lynn Briscoe · Leidos Biomedical Research, Inc.$225,263,761
- Leonard Freedmand · Leidos Biomedical Research, Inc.$160,413,316
- Robert H Waterston · Washington University$155,287,704
Research focus
LibrariesLeadCyclic PeptidesSideVertebral ColumnMembranePeptidesCellsPermeabilityScaffoldCell Membrane PermeabilitySmall MoleculeBaseProgramsPharmaceutical PreparationsAffinityLipid BilayersNatural ProductsExhibitsBiochemicalDiffusionBiologicalMolecular ConformationPositioning Attribute
Grant awards (23)
Advancing the basic science of membrane permeability in macrocyclic peptides$371,505
R35 · FY2025 · GM · contact PI
Advancing the basic science of membrane permeability in macrocyclic peptides$371,505
R35 · FY2024 · GM · contact PI
Mass-directed preparative HPLC purification system$239,341
R35 · FY2024 · GM · contact PI
Advancing the basic science of membrane permeability in macrocyclic peptides$371,505
R35 · FY2023 · GM · contact PI
Cyclic peptide permeability$308,000
R01 · FY2022 · GM · contact PI
Upgrade of core imaging instrumentation and robotics for the UCSC Chemical Screening Center$1,931,837
S10 · FY2021 · OD · contact PI
Cyclic peptide permeability$308,000
R01 · FY2021 · GM · contact PI
Cyclic peptide permeability$308,000
R01 · FY2020 · GM · contact PI
Cyclic peptide permeability$308,000
R01 · FY2019 · GM · contact PI
Cyclic peptide permeability$92,609
R01 · FY2019 · GM · contact PI
Synthesis and discovery of biologically active cell-permeable cyclic peptides$284,955
R01 · FY2012 · GM · contact PI
Synthesis and discovery of biologically active cell-permeable cyclic peptides$286,722
R01 · FY2011 · GM · contact PI
Synthesis and discovery of biologically active cell-permeable cyclic peptides$308,201
R01 · FY2010 · GM · contact PI
Synthesis and discovery of biologically active cell-permeable cyclic peptides$94,714
R01 · FY2010 · GM · contact PI
Synthesis and discovery of biologically active cell-permeable cyclic peptides$324,171
R01 · FY2009 · GM · contact PI
NCRR: UCSC Integrated Small Molecule Screening Facility$500,000
S10 · FY2007 · RR · contact PI
Small Molecule Modulators of the Actin Cytoskeleton$248,287
R01 · FY2007 · CA · contact PI
Small Molecule Modulators of the Actin Cytoskeleton$255,905
R01 · FY2006 · CA · contact PI
Small Molecule Modulators of the Actin Cytoskeleton$262,256
R01 · FY2005 · CA
Small Molecule Modulators of the Actin Cytoskeleton$262,435
R01 · FY2004 · CA
Small Molecule Modulators of the Actin Cytoskeleton$296,766
R01 · FY2003 · CA
NOVEL CYCLIC-PEPTIDE-BASED ANTIMITOTICS$5,583
F32 · FY2001 · GM
NOVEL CYCLIC-PEPTIDE-BASED ANTIMITOTICS$37,516
F32 · FY2000 · GM